These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9335053)

  • 1. Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist.
    Ciapponi L; Maione D; Scoumanne A; Costa P; Hansen MB; Svenson M; Bendtzen K; Alonzi T; Paonessa G; Cortese R; Ciliberto G; Savino R
    Nat Biotechnol; 1997 Oct; 15(10):997-1001. PubMed ID: 9335053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist.
    De Benedetti F; Pignatti P; Vivarelli M; Meazza C; Ciliberto G; Savino R; Martini A
    J Immunol; 2001 Apr; 166(7):4334-40. PubMed ID: 11254686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
    Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
    Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6: an antagonizing problem becomes a solution.
    Rettig MB
    Nat Biotechnol; 1997 Oct; 15(10):952-3. PubMed ID: 9335041
    [No Abstract]   [Full Text] [Related]  

  • 5. Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the bioactivity of human IL-6 in mice.
    Mihara M; Koishihara Y; Fukui H; Yasukawa K; Ohsugi Y
    Immunology; 1991 Sep; 74(1):55-9. PubMed ID: 1718855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of IL-6 in transgenic mice results in increased levels of the 90 kDa heat shock protein (hsp90) and the production of anti-hsp90 antibodies.
    Stephanou A; Conroy S; Isenberg DA; Maione D; Poli V; Ciliberto G; Latchman DS
    J Autoimmun; 1998 Jun; 11(3):249-53. PubMed ID: 9693973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
    Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
    Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine IL-4 is able to signal via chimeric human IL-4Ralpha/mouse gamma-chain receptor.
    Myburgh E; Horsnell WG; Cutler AJ; Arendse B; Kubo M; Brombacher F
    Mol Immunol; 2008 Mar; 45(5):1327-36. PubMed ID: 18029018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.
    Galle P; Jensen L; Andersson C; Cuzzocrea S; Di Paola R; Nicoletti F; Svenson M; Bendtzen K; Thomsen AR; Hansen MB
    Int Immunopharmacol; 2007 Dec; 7(13):1704-13. PubMed ID: 17996680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis.
    Suzuki H; Takemura H; Yoshizaki K; Koishihara Y; Ohsugi Y; Okano A; Akiyama Y; Tojo T; Kishimoto T; Kashiwagi H
    J Immunol; 1994 Jan; 152(2):935-42. PubMed ID: 8283060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.
    Foussat A; Wijdenes J; Bouchet L; Gaidano G; Neipel F; Balabanian K; Galanaud P; Couderc J; Emilie D
    Eur Cytokine Netw; 1999 Dec; 10(4):501-8. PubMed ID: 10586116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
    Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
    Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.
    Koike M; Nakamura K; Furuya A; Iida A; Anazawa H; Takatsu K; Hanai N
    Hum Antibodies; 2009; 18(1-2):17-27. PubMed ID: 19478395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors.
    Galle P; Svenson M; Bendtzen K; Hansen MB
    Eur J Immunol; 2004 Nov; 34(11):3267-75. PubMed ID: 15368270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of a human IL-6 antagonist.
    Saggio I; Ciapponi L; Savino R; Ciliberto G; Perricaudet M
    Gene Ther; 1997 Aug; 4(8):839-45. PubMed ID: 9338013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
    Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
    J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.
    De Giovanni C; Nicoletti G; Landuzzi L; Astolfi A; Croci S; Comes A; Ferrini S; Meazza R; Iezzi M; Di Carlo E; Musiani P; Cavallo F; Nanni P; Lollini PL
    Cancer Res; 2004 Jun; 64(11):4001-9. PubMed ID: 15173014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.
    Wüstefeld T; Rakemann T; Kubicka S; Manns MP; Trautwein C
    Hepatology; 2000 Sep; 32(3):514-22. PubMed ID: 10960443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.